title: Cost-effective Strategies for the Management and Treatment of Urethral Stricture Disease.
abstract: Following failed endoscopic intervention, the most cost-effective strategy for recurrent urethral stricture disease (USD) is urethroplasty. Inpatient hospital costs associated with urethroplasty are driven by patient comorbidities and postoperative complications. Symptom-based surveillance for USD recurrence will reduce unnecessary diagnostic procedures and cost.
authors.affiliation: Department of Urology, University of California, San Francisco, 400 Parnassus Ave, San Francisco, CA 94143, USA.
authors.forename: E Charles
authors.initials: EC
authors.lastname: Osterberg
authors.affiliation: Department of Urology, University of California, San Francisco, 400 Parnassus Ave, San Francisco, CA 94143, USA.
authors.forename: Gregory
authors.initials: G
authors.lastname: Murphy
authors.affiliation: Department of Urology, University of California, San Francisco, 400 Parnassus Ave, San Francisco, CA 94143, USA; Department of Urology, Stanford University, 300, Palo Alto, CA 94304, USA.
authors.forename: Catherine R
authors.initials: CR
authors.lastname: Harris
authors.affiliation: Department of Urology, University of California, San Francisco, 400 Parnassus Ave, San Francisco, CA 94143, USA. Electronic address: Benjamin.breyer@ucsf.edu.
authors.forename: Benjamin N
authors.initials: BN
authors.lastname: Breyer
mesh_terms: D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D019468:Disease Management; D017408:Guidelines as Topic; D006801:Humans; D008297:Male; D014521:Urethra / Q000601:surgery*; D014525:Urethral Stricture / Q000191:economics* / Q000601:surgery*; D013521:Urologic Surgical Procedures, Male / Q000191:economics*
keywords: Cost-effectiveness; Urethroplasty; Utilization